These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21651497)

  • 1. Protein kinases in cancer: recent findings.
    Schenone S
    Curr Med Chem; 2011; 18(19):2826. PubMed ID: 21651497
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
    Huang Z; Lee MH
    Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein kinases as drug targets.
    Yli-Kauhaluoma J; Tuominen RK
    Curr Top Med Chem; 2011; 11(11):1304. PubMed ID: 21513501
    [No Abstract]   [Full Text] [Related]  

  • 4. Promises and drawbacks of targeting cell cycle kinases in cancer.
    Pentimalli F; Giordano A
    Discov Med; 2009 Dec; 8(43):177-80. PubMed ID: 20040266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations of protein kinases and individualised cancer therapy.
    Davies M; Hennessy B; Mills GB
    Expert Opin Pharmacother; 2006 Nov; 7(16):2243-61. PubMed ID: 17059381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies.
    Bagrodia S; Smeal T; Abraham RT
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):819-31. PubMed ID: 22883054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents.
    Liu Y; Wan WZ; Li Y; Zhou GL; Liu XG
    Oncotarget; 2017 Jan; 8(4):7181-7200. PubMed ID: 27769061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase Inhibitor Screening in Myeloid Malignancies.
    Tyner JW
    Hematol Oncol Clin North Am; 2017 Aug; 31(4):693-704. PubMed ID: 28673396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
    Morris MC
    Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding the computational toolbox for interrogating cancer kinomes.
    Tan AC; Ryall KA; Huang PH
    Pharmacogenomics; 2016; 17(2):95-7. PubMed ID: 26666839
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.
    Carlino L; Rastelli G
    J Med Chem; 2016 Oct; 59(20):9305-9320. PubMed ID: 27559828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of targeting protein kinases in cancer therapeutics.
    Tsai CJ; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):235-42. PubMed ID: 23651790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation.
    Trusolino L; Bertotti A
    Cancer Discov; 2012 Oct; 2(10):876-80. PubMed ID: 23071031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinase inhibitors and their resistance].
    Togashi Y; Nishio K
    Nihon Rinsho; 2015 Aug; 73(8):1323-9. PubMed ID: 26281685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
    Fabbro D
    Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer with kinase inhibitors.
    Gross S; Rahal R; Stransky N; Lengauer C; Hoeflich KP
    J Clin Invest; 2015 May; 125(5):1780-9. PubMed ID: 25932675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten things you should know about protein kinases: IUPHAR Review 14.
    Fabbro D; Cowan-Jacob SW; Moebitz H
    Br J Pharmacol; 2015 Jun; 172(11):2675-700. PubMed ID: 25630872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the selectivity of kinase inhibitors in oncology: a chemical biology perspective.
    Maddox S; Hecht D; Gustafson JL
    Future Med Chem; 2016; 8(3):241-4. PubMed ID: 26898835
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.